University of Chicago Comprehensive Cancer Center at Silver Cross Hospital is a clinical research site located in New Lenox, Illinois, United States 60451.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Chicago Comprehensive Cancer Center at Silver Cross Hospital has participated in 15 clinical trials with 7 currently active.
Therapeutic areas: Ovarian Neoplasms, Endometrial Neoplasms, Breast Neoplasms.
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer, Dana-Farber Cancer Institute.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Chicago Comprehensive Cancer Center at Silver Cross Hospital has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Chicago Comprehensive Cancer Center at Silver Cross Hospital has 15 clinical trials on record, with 7 currently active. Their work covers Ovarian Neoplasms, Endometrial Neoplasms, Breast Neoplasms.
Yes — University of Chicago Comprehensive Cancer Center at Silver Cross Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.